tradingkey.logo

tradingkey.logo
怜玢


Artivion Inc

AORT
りォッチリストに远加
22.770USD
-0.170-0.74%
終倀 05/15, 16:00ET15分遅れの株䟡
1.11B時䟡総額
88.74盎近12ヶ月PER


詳现情報 Artivion Inc 䌁業名

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Artivion Incの䌁業情報


䌁業コヌドAORT
䌚瀟名Artivion Inc
䞊堎日Feb 12, 1993
最高経営責任者「CEO」Mackin (James Patrick)
埓業員数1600
蚌刞皮類Ordinary Share
決算期末Feb 12
本瀟所圚地1655 Roberts Boulevard N W
郜垂KENNESAW
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United States of America
郵䟿番号30144
電話番号17704193355
りェブサむトhttps://artivion.com/
䌁業コヌドAORT
䞊堎日Feb 12, 1993
最高経営責任者「CEO」Mackin (James Patrick)

Artivion Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
--
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
--
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
--
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
68.65K
--
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
53.80K
--
Dr. Marshall S. Stanton, M.D.
Dr. Marshall S. Stanton, M.D.
Senior Vice President, Clinical Research and Chief Medical Officer
Senior Vice President, Clinical Research and Chief Medical Officer
39.13K
+34.61%
Mr. Matthew A. (Matt) Getz
Mr. Matthew A. (Matt) Getz
Vice President - Human Resources
Vice President - Human Resources
34.12K
-27.61%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
--
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
--
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
--

収益内蚳

通貚: USD曎新時刻: Mon, Apr 6
通貚: USD曎新時刻: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
䌚瀟名
収益
比率
Aortic stent grafts
159.37M
36.11%
On X
101.74M
23.05%
Preservation Services
95.50M
21.64%
Bio Glue
76.60M
17.36%
Surgical sealants
76.60M
17.36%
Other
8.11M
1.84%
地域別USD
䌚瀟名
収益
比率
International
227.25M
51.49%
United States
214.07M
48.51%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Aortic stent grafts
159.37M
36.11%
On X
101.74M
23.05%
Preservation Services
95.50M
21.64%
Bio Glue
76.60M
17.36%
Surgical sealants
76.60M
17.36%
Other
8.11M
1.84%

株䞻

曎新時刻: Sun, May 10
曎新時刻: Sun, May 10
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
BlackRock Institutional Trust Company, N.A.
12.17%
Nomura Investment Management Business Trust
5.38%
Fidelity Management & Research Company LLC
4.98%
Vanguard Capital Management, LLC
4.02%
Morgan Stanley Smith Barney LLC
3.78%
他の
69.67%
株䞻統蚈
株䞻統蚈
比率
BlackRock Institutional Trust Company, N.A.
12.17%
Nomura Investment Management Business Trust
5.38%
Fidelity Management & Research Company LLC
4.98%
Vanguard Capital Management, LLC
4.02%
Morgan Stanley Smith Barney LLC
3.78%
他の
69.67%
皮類
株䞻統蚈
比率
Investment Advisor
50.56%
Investment Advisor/Hedge Fund
32.13%
Individual Investor
4.67%
Hedge Fund
4.36%
Private Equity
3.55%
Research Firm
1.49%
Pension Fund
1.01%
Bank and Trust
0.42%
Venture Capital
0.03%
他の
1.76%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
449
45.29M
93.40%
+501.67K
2025Q4
410
43.29M
91.25%
+30.07K
2025Q3
417
43.26M
91.49%
+621.40K
2025Q2
388
42.72M
90.85%
+749.95K
2025Q1
378
41.65M
93.88%
+1.56M
2024Q4
361
38.77M
90.20%
+1.92M
2024Q3
344
36.62M
88.99%
+563.89K
2024Q2
325
36.03M
88.04%
+491.62K
2024Q1
322
35.76M
90.55%
-2.03M
2023Q4
321
34.94M
89.27%
+12.56K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
BlackRock Institutional Trust Company, N.A.
5.91M
12.33%
+292.30K
+5.21%
Dec 31, 2025
Nomura Investment Management Business Trust
2.61M
5.46%
+129.63K
+5.22%
Dec 31, 2025
Fidelity Management & Research Company LLC
2.42M
5.05%
-420.69K
-14.81%
Dec 31, 2025
Morgan Stanley Smith Barney LLC
1.83M
3.83%
-32.21K
-1.73%
Dec 31, 2025
Perceptive Advisors LLC
1.72M
3.6%
-297.71K
-14.74%
Dec 31, 2025
State Street Investment Management (US)
1.58M
3.31%
+44.64K
+2.90%
Dec 31, 2025
Wellington Management Company, LLP
1.41M
2.94%
-95.68K
-6.37%
Dec 31, 2025
Fred Alger Management, LLC
1.37M
2.87%
+55.32K
+4.20%
Dec 31, 2025
Juniper Investment Company, LLC
1.19M
2.48%
-144.56K
-10.84%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
AAM Sawgrass US Small Cap Quality Growth ETF
4.14%
Unusual Whales Subversive Democratic Trading ETF
3.4%
ROBO Global Healthcare Technology & Innovation ETF
1.85%
State Street SPDR S&P Health Care Equipment ETF
1.74%
Invesco S&P SmallCap Health Care ETF
1.15%
Invesco Dorsey Wright Healthcare Momentum ETF
0.76%
Invesco S&P SmallCap 600 Pure Growth ETF
0.69%
First Trust Small Cap Growth AlphaDEX Fund
0.64%
Invesco Dorsey Wright SmallCap Momentum ETF
0.42%
iShares Micro-Cap ETF
0.33%
詳现を芋る
AAM Sawgrass US Small Cap Quality Growth ETF
比率4.14%
Unusual Whales Subversive Democratic Trading ETF
比率3.4%
ROBO Global Healthcare Technology & Innovation ETF
比率1.85%
State Street SPDR S&P Health Care Equipment ETF
比率1.74%
Invesco S&P SmallCap Health Care ETF
比率1.15%
Invesco Dorsey Wright Healthcare Momentum ETF
比率0.76%
Invesco S&P SmallCap 600 Pure Growth ETF
比率0.69%
First Trust Small Cap Growth AlphaDEX Fund
比率0.64%
Invesco Dorsey Wright SmallCap Momentum ETF
比率0.42%
iShares Micro-Cap ETF
比率0.33%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™